Skip to main content
Our Medicines
Contact Us
Careers
United Kingdom
Close Icon
Americas
Argentina
Spanish
Brazil
Portuguese
Canada
English
/
French
Chile
Spanish
Colombia
Spanish
Mexico
Spanish
Peru
Spanish
United States
English
Asia Pacific
Australia
English
China
Simplified Chinese
India
English
Japan
Japanese
Korea
Korean
New Zealand
English
Singapore
English
Taiwan
Traditional Chinese
Thailand
English
/
Thai
Europe
Austria
German
Belgium
English
/
Dutch
/
French
Czech Republic
Czech
Denmark
Norwegian
Finland
Finnish
France
French
Germany
German
Greece
Greek
Hungary
Hungarian
Ireland
English
Italy
Italian
Luxembourg
English
Netherlands
English
/
Dutch
Norway
Norwegian
Poland
Poland
Portugal
Portuguese
Romania
Romanian
Spain
Spanish
Sweden
Swedish
Switzerland
German
/
French
United Kingdom
English
Middle East
Israel
Hebrew
Saudi Arabia
Arabic
/
English
Turkey
Turkish
United Arab Emirates
Arabic
/
English
Other
Other Markets
Distributor Markets
Previous Page Icon
Previous Page Icon
Our Medicines
Patients & Caregivers
Healthcare Providers
Medical education resources
Researchers & Partners
Our Therapy Areas
News & Perspectives
Media
About Us
Our Mission
Our Principles
Responsibility
Next Page Icon
Partnering
Transparency
Grants, Giving & Corporate Sponsorship Support
UK Tax Strategy
Inclusion & Diversity
Donations & Grants
Sustainability
Doing Business with Us as a Supplier
Contact Us
Our Site at Chester
Our Site at Moreton
Our Site at Uxbridge
Life Sciences 2030
People and Business Resource Groups
More than Inherited Cardiac Conditions (ICCs): BMS launches report at parliamentary summit for improving outcomes in ICCs
Search
Search
Search
Bristol Myers Squibb - Global Biopharmaceutical Company
Health Hub
Our Stories
Learn more
Lung cancer experts address unwarranted variation in diagnosis and treatment
>
Bristol Myers Squibb expands health equity grant initiatives to improve health outcomes
>
NEXT
Sustainability >
Joint working >
Financial disclosures >
Medical information for healthcare providers >
Clinical trials >
Our Therapy Areas >
NO-GB-2600019
Date of preparation: March 2026
